Spain Pharmaceuticals and Healthcare Report Q3 2014

The weakened Spanish economy and the government's ongoing multi-faceted strategy to contain expenditure on prescription medicines by targeting patients, companies and the overall healthcare sector present challenges to drugmakers operating in the country.